Adheris Health Limited has released a press release.
MDR Signs Agreement with EBOS Subsidiary ZEST
Filed with ASX ·
Watch Adheris Health's latest callMedAdvisor Limited (MDR) Q1 2026 Earnings Call · Replay · Oct 21, 2025Read the transcript of MedAdvisor Limited (MDR) Q1 2026 Earnings Call6ix hasn’t read this filing yet.
Story so far
Earlier from Adheris Health
- MedAdvisor to Launch Customised TerryWhite Chemmart App
- MDR March 2018 Quarterly Report & Appendix 4C
- MDR H1 FY2018 Financial Report & Appendix 4D
- MDR December 2017 Quarterly Report & Appendix 4C
- MedAdvisor $9.5m Investment from EBOS
Later from Adheris Health
- Co-Marketing & Licence Agreement with US Dispense Vendor PDX
- MedAdvisor and HPS Announce Integrated Medication Solution
- MedAdvisor FY18 Annual Report & Appendix 4E
- MedAdvisor Expands Revenue Streams in Clinical Trials
- PEP and International Update
Follow Adheris Health into a list and get an email when it puts out news.
Follow Adheris Health